JANUX THERAPEUTICS INC shareholders Q3 2023

JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

JANUX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN STANLEY 20,456$206,1960.00%
AMALGAMATED BANK 1,766$180.00%
BANK OF MONTREAL /CAN/ 98,429$1,077,7980.00%
BlackRock Inc. 1,639,579$16,526,9560.00%
Bank of New York Mellon Corp 53,049$534,7340.00%
Citadel Advisors 2,400$24,1920.00%
Citadel Advisors 400$4,0320.00%
Renaissance Technologies 26,100$2630.00%
Swiss National Bank 22,800$229,8240.00%
Qube Research & Technologies Ltd 8,735$88,0490.00%
Allspring Global Investments Holdings, LLC 1,159$11,6820.00%
Tower Research Capital LLC (TRC) 1,308$13,1850.00%
JPMORGAN CHASE & CO 148,609$1,497,9780.00%
VANGUARD GROUP INC 942,281$9,498,1930.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 13,073$131,7760.00%
ALLIANCEBERNSTEIN L.P. 16,860$169,9490.00%
RHUMBLINE ADVISERS 26,532$267,4330.00%
Squarepoint Ops LLC 10,647$107,3220.00%
ROYAL BANK OF CANADA 3,397$34,0000.00%
Nuveen Asset Management, LLC 66,702$672,3560.00%
External links

This page lists JANUX THERAPEUTICS INC's shareholders in Q3 2023. To view JANUX THERAPEUTICS INC's shareholder history, click here.